General Information of Drug (ID: DR1739)
Drug Name
Zotepine
Synonyms
Zoleptil; Zotepina; Zotepina [INN-Spanish]; Zotepina [Spanish]; Zotepinum; Zotepinum [INN-Latin]; Lodopin; Nipolept; Compound-4; HDOZVRUNCMBHFH-UHFFFAOYSA-N; U29O83JAZW; zotepine; 2-Chlor-11-(2-dimethylaminoaethoxy)-dibenzo(b,f)-thiepin; 2-Chloro-11-(2-(dimethylamino)ethoxy)dibenzo(b,f)thiepin; 2-Chloro-11-(2-dimethylaminoethoxy)-dibenzo(b,f)thiepine; 2-[(8-chlorodibenzo[b,f]thiepin-10-yl)oxy]-N,N-dimethylethanamine; 26615-21-4; BRN 1435710; C18H18ClNOS; CHEBI:32316; CHEMBL285802; NCGC00182081-02; UNII-U29O83JAZW
Indication Schizophrenia [ICD11: 6A20] Phase 4 [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 331.9 Topological Polar Surface Area 37.8
Heavy Atom Count 22 Rotatable Bond Count 4
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 3
Cross-matching ID
PubChem CID
5736
PubChem SID
5375173 ; 7848384 ; 7980920 ; 8153517 ; 12013422 ; 14899864 ; 29224773 ; 48416715 ; 49658668 ; 49832081 ; 49962436 ; 57322922 ; 74607145 ; 85174240 ; 85209606 ; 85753334 ; 91749410 ; 92729688 ; 103195284 ; 103993496 ; 104310109 ; 109613401 ; 114919769 ; 118313787 ; 124893805 ; 124893806 ; 125346524 ; 128045577 ; 131308055 ; 134341323 ; 134996843 ; 135651367 ; 137001502 ; 142405042 ; 144206686 ; 162175576 ; 162248926 ; 164829244 ; 170465934 ; 175611849 ; 179150247 ; 198951716 ; 224543978 ; 226486877 ; 250133641 ; 252157701 ; 252418861 ; 252450828
ChEBI ID
CHEBI:32316
CAS Number
26615-21-4
TTD Drug ID
D0T6QX
Formula
C18H18ClNOS
Canonical SMILES
CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(C=C3)Cl
InChI
1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3
InChIKey
HDOZVRUNCMBHFH-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
2-OH-zotepine DM015814
12882318
Oxidation - Aromatic hydroxylation 1 [4]
3-OH-zotepine DM015815
12882320
Oxidation - Aromatic hydroxylation 1 [4]
Norzotepine DM015604
10041551
Oxidation - N-demethylation 1 [4] , [5]
Zotepine N-oxide DM015826
13309858
Oxidation - N-oxidation 1 [4]
Zotepine S-oxide DM015813
12882299
Oxidation - S-oxidation 1 [4]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR013081 Zotepine Norzotepine Oxidation - N-demethylation CYP1A1 ... [4], [5]
MR013082 Zotepine Zotepine N-oxide Oxidation - N-oxidation CYP3A4 ... [4]
MR013083 Zotepine 2-OH-zotepine Oxidation - Aromatic hydroxylation CYP1A2 [4]
MR013084 Zotepine 3-OH-zotepine Oxidation - Aromatic hydroxylation CYP1A1 ... [4]
MR013085 Zotepine Zotepine S-oxide Oxidation - S-oxidation CYP1A1 ... [4]
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Cytochrome P450 1A1 (CYP1A1) DME0006 Homo sapiens
CP1A1_HUMAN
1.14.14.1
[2]
Cytochrome P450 1A2 (CYP1A2) DME0003 Homo sapiens
CP1A2_HUMAN
1.14.14.1
[2]
Cytochrome P450 2B6 (CYP2B6) DME0020 Homo sapiens
CP2B6_HUMAN
1.14.14.1
[2]
Cytochrome P450 2D6 (CYP2D6) DME0009 Homo sapiens
CP2D6_HUMAN
1.14.14.1
[2]
Cytochrome P450 3A4 (CYP3A4) DME0001 Homo sapiens
CP3A4_HUMAN
1.14.14.55
[3]
Cytochrome P450 3A5 (CYP3A5) DME0012 Homo sapiens
CP3A5_HUMAN
1.14.14.1
[4]
Dimethylaniline oxidase 3 (FMO3) DME0039 Homo sapiens
FMO3_HUMAN
1.14.13.8
[4]
Mephenytoin 4-hydroxylase (CYP2C19) DME0021 Homo sapiens
CP2CJ_HUMAN
1.14.14.1
[4]
⏷ Show the Full List of 8  DME(s)
References
1 ClinicalTrials.gov (NCT00418873) Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward.
2 Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes. Xenobiotica. 1999 Mar;29(3):217-29.
3 New antipsychotic agents for schizophrenia: pharmacokinetics and metabolism update. Curr Opin Investig Drugs. 2002 Jul;3(7):1073-80.
4 Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. Curr Med Chem. 2009;16(31):4066-218.
5 Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.